Biophytis S.A. (EPA:ALBPS)
0.0525
-0.0143 (-21.41%)
Sep 11, 2026, 5:35 PM CET
Biophytis Market Cap
Biophytis has a market cap or net worth of €4.81 million as of September 11, 2026. Its market cap has increased by 22.77% in one year.
Market Cap
4.81M
Enterprise Value
11.29M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.05
ChartMarket Cap Chart
Since July 13, 2015, Biophytis's market cap has decreased from 45.17M to 4.81M, a decrease of -89.35%. That is a compound annual growth rate of -18.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 4.81M | 210.95% |
| Dec 31, 2025 | 1.55M | -44.45% |
| Dec 31, 2024 | 2.78M | -23.40% |
| Dec 29, 2023 | 3.64M | -51.74% |
| Dec 30, 2022 | 7.53M | -87.89% |
| Dec 31, 2021 | 62.22M | -32.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 22.77M |
| Aelis Farma | 13.60M |
| Advicenne | 12.60M |
| Aton | 11.59M |
| NFL Biosciences | 10.64M |
| TME Pharma | 10.31M |
| Poxel | 9.69M |
| Quantum Genomics Société Anonyme | 5.02M |